|Study Description:||The goal of Phase 1 of this clinical research study is to find the highest |
tolerable dose and best schedule of the combination of everolimus and sorafenib
that can be given to patients with malignant glioma.
The goal of Phase 2 of this study to learn if the combination of everolimus and
sorafenib can help to control malignant glioma. The safety of this combination
will also be studied in both phases.